Development

Mobile App for Autism Screening Yields Useful Data

A Duke study of an iPhone app to screen young children for signs of autism has found that the app is easy to use, welcomed by caregivers and good at producing reliable scientific data. The study, described June 1 in an open access journal npj Digital Medicine, points the way to broader, easier access to screening for autism and other neurodevelopmental disorders.

mHealth as Effective as Clinic-Based Intervention for People with Serious Mental Illness

A mobile health (mHealth) intervention was found to be as effective as a clinic-based group intervention for people with serious mental illness in a new study published online in Psychiatric Services. In a randomized controlled trial, researchers compared an mHealth approach (FOCUS), using mobile phones to deliver intervention, to a more traditional clinic-based group intervention, the Wellness Recovery Action Plan (WRAP).

New Computational Tool could Help Optimize Treatment of Alzheimer's Disease

Scientists have developed a novel computational approach that incorporates individual patients' brain activity to calculate optimal, personalized brain stimulation treatment for Alzheimer's disease. Lazaro Sanchez-Rodriguez of the University of Calgary, Canada, and colleagues present their new framework in PLOS Computational Biology.

Ingestible 'Bacteria on a Chip' could Help Diagnose Disease

MIT researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. This "bacteria-on-a-chip" approach combines sensors made from living cells with ultra-low-power electronics that convert the bacterial response into a wireless signal that can be read by a smartphone.

New Study Reveals How Electronic Health Records can Benefit Clinical Trials

The study entitled "Long term extension of a randomised controlled trial of probiotics using electronic health records" led by researchers in the Swansea University Medical School and the College of Human and Health Sciences, was published in Scientific Reports. The findings demonstrate the potential of using anonymised routinely collected electronic health records, such as those linked in SAIL, for more complete trial results.

Innovative Medicines Initiative Launches 100th Project

The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).

The Big Ethical Questions for Artificial Intelligence in Healthcare

AI in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. The Nuffield Council on Bioethics examines the current and potential applications of AI in healthcare, and the ethical issues arising from its use, in a new briefing note, Artificial Intelligence (AI) in healthcare and research, published today.

Research and Development News

Mobile App for Autism Screening Yields Useful Data

mHealth as Effective as Clinic-Based Intervention for People with Serious Mental Illness

New Computational Tool could Help Optimize Treatment of Alzheimer's Disease

Ingestible 'Bacteria on a Chip' could Help Diagnose Disease

New Study Reveals How Electronic Health Records can Benefit Clinical Trials

Innovative Medicines Initiative Launches 100th Project

The Big Ethical Questions for Artificial Intelligence in Healthcare

More eHealth News ...

Latest Business News

Latest Research News

Latest Conferences News

Latest Jobs